The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...

GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the ...

GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...

Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...

Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from ...

Micron stock surges after strong earnings and guidance, fellow chip makers such as Nvidia and ASML rally, Southwest Airlines ...

The Moat Index's quarterly review maintained sector biases, favoring industrials and underweighting tech, while focusing on ...

In a report released yesterday, Ryan Zimmerman from BTIG upgraded GE Healthcare Technologies Inc (GEHC – Research Report) to a Buy, with ...

GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...

Investing.com -- UBS has downgraded GE Healthcare Technologies Inc (NASDAQ: GEHC ). to a 'sell' rating from a 'neutral' ...